DLC1 Lysate (NBL1-09907)
DLC1 Lysate
|
This product is fully covered under the Novus guarantee+ Policy.
Click
here for details.
|
|
Distributor Data...
|
|
ARHGAP7, STARD12, p122-RhoGAP, HP, FLJ21120 |
|
|
DLC1 Lysate Summary: | | | Specificity: | Homo sapiens deleted in liver cancer 1 (DLC1), transcript variant 2, mRNA. |
|---|
| |
| | Note: Not all species have been tested for usefulness with this product. Only those species listed have been tested. We cannot make any guarantees about additional reactivities which may or may not occur. |
View Additional DLC1 Products DLC1 Lysate Details: | Immunogen: | The lysate was created in HEK293T cells, using plasmid ID RC213320 and based on accession number NM_006094. The protein contains a C-terminal DDK tag. |
|---|
Lysate Details: | Type: | Overexpression | Life Stage: | Adult | | Protein State: | Native | Tissue Condition: | Normal | | Sub-cellular Fraction: | Whole |
| Uses: | This product is intended for use as a positive control in Western Blot. You will receive the lysate (100ug), and an empty vector negative control (100 ug). |
|---|
| Dilutions: | Western Blot |
|---|
| TMW: | 122.6 kDa |
|---|
| Unit Size: | 0.1 mg |
|---|
| Concentration: | 1.0 mg/ml |
|---|
|
Notes: This product is manufactured by and sold under license from OriGene Technologies and its use is limited solely for research purposes. Please note that “1 mg/ml” refers to the total protein concentration and that the specific protein concentration is not determined at this time. Packaging: | Storage: | Store at -80 °C. Avoid freeze-thaw cycles. |
|---|
| Buffer: | RIPA buffer |
|---|
| Limitations: | This product is for research use only and is not approved for use in humans or in clinical diagnosis. Products are guaranteed for 6 months from date of receipt, except for peptides and proteins which are guaranteed for 3 months. |
|---|
Background: This gene is deleted in the primary tumor of hepatocellular carcinoma. It maps to 8p22-p21.3, a region frequently deleted in solid tumors. It is suggested that this gene is a candidate tumor suppressor gene for human liver cancer, as well as for prostate, lung, colorectal, and breast cancers. Alternative splicing at this locus results in several transcript variants encoding different isoforms. [provided by RefSeq]. Transcript Variant: This variant (2) has a novel 5' end exon compared to transcript variant 1, resulting in a shorter isoform (2) with a different N-terminus compared to isoform 1. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
|
Images (1) Reviews (0) Related Products (16)
|
Jump to: Images, Ask a Question
|
Working with DLC1
DLC1 Lysate Images (1) Western Blot: DLC1 Lysate [NBL1-09907] - Western Blot experiments.
Left-Control; Right -Over-expression Lysate for DLC1 |
|
|
|
|
|
|
|
Ask a Scientist
Can't find an answer to your question about DLC1? Ask us by using live
chat or by submitting your questions below:
|
Jump to: Antibody Pairs, Lysates, Primary Antibodies
|
Related ProductsAntibody Pairs (1)Lysates (3)Primary Antibodies (10)| Name | Catalog# | Reactivity | Applications | Images | Publications | Reviews | |
|---|
| DLC1 Antibody | NBP1-87977 | Hu | IF, IHC-P, WB | (2) | | | | | DLC1 Antibody | NBP1-87978 | Hu | IF, IHC-P, WB | (1) | | | | | DLC1 Antibody | NBP1-88824 | Hu | IF, IHC-P, WB | (1) | | | | | DLC1 Antibody | NB300-917 | Hu, Mu | PEP-ELISA | (1) | (2) | | | | DLC1 Antibody | NBP1-68133 | Hu, Mu, Rt | ELISA, IF, IHC | | | | | | ... and 5 more. See All » |
|
|
